Does the CHA2DS2-VASc score perform better than CHADS2 for predicting thromboembolism, and how does HAS-BLED perform for bleeding risk in patients with atrial fibrillation?
182,678 patients with atrial fibrillation from the Swedish Atrial Fibrillation cohort study
CHA2DS2-VASc and HAS-BLED risk stratification schemes
CHADS2 and other bleeding risk schemes
Ischaemic stroke and/or composite thromboembolism endpoint, and bleedingcomposite
The CHA2DS2-VASc and HAS-BLED scores are effective and practical tools for predicting thromboembolism and bleeding risks in patients with atrial fibrillation.
Several independent risk factors (prior ICH, myocardial infarction, vascular disease, and renal failure) predict ischaemic stroke and/or the composite thromboembolism endpoint in AF, but thyroid disease (or hyperthyroidism) was not an independent risk factor for stroke. There is a better performance for CHA(2)DS(2)-VASc over CHADS(2) schemes for the composite thromboembolism endpoint. While both tested bleeding risk schemes have similar predictive value, the HAS-BLED score has the advantage of simplicity.
Building similarity graph...
Analyzing shared references across papers
Loading...
Friberg et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69db5288f7e0c66ced8359bd — DOI: https://doi.org/10.1093/eurheartj/ehr488
Leif Friberg
Mårten Rosenqvist
Gregory Y.H. Lip
European Heart Journal
Karolinska Institutet
University of Birmingham
Birmingham City Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...